Clinical trial
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML)…
NCT00242515 · National University Hospital, Singapore, Other · Unknown status
Key facts
| NCT number | NCT00242515 |
|---|---|
| Title | T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) |
| Official title | Preemptive CD8+ T-cell Depleted Donor Lymphocyte Infusion (DLI) Following Nonmyeloablative Stem Cell Transplantation (NMT) for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) |
| Lead sponsor | National University Hospital, Singapore, Other |
| Collaborators | Singapore General Hospital |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Myelodysplastic Syndromes |
| Intervention type | Procedure |
| Interventions | CD8+ T-cell depleted donor lymphocyte infusion |
| Enrollment | 16 |
| Start date | Mar 1, 2005 |
| Completion | Mar 1, 2008 |
| First posted | Oct 20, 2005 |
| Last update posted | Jan 8, 2014 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: